bmiMD vs MEDVi Quad

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

bmiMD vs MEDVi Quad: Overview

Choosing between bmiMD and MEDVi Quad for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.

bmiMD offers both semaglutide and tirzepatide at $129/month with a rating of 8/10. MEDVi Quad also provides both semaglutide and tirzepatide at $114/month with a 6.5/10 rating.

With only a $15/month price difference, your choice will likely come down to features, support quality, and medication options.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$15/mo
Rating Difference
1.5
Winner
bmiMD
Best For
Quality

bmiMD

View full bmiMD review →
Rating
8/10Better
Monthly Price
$129
Medications
semaglutidetirzepatidemetformin

Pros

  • The full price ladder is published on the product page, not hidden behind a quiz: compounded semaglutide is $129 billed monthly, $119/mo on 3 months ($357), $109/mo on 6 months ($654) and $99/mo on 12 months ($1,188), checked July 26, 2026
  • You are not charged until a licensed provider confirms you are eligible. bmiMD authorises your card, releases the hold if you do not qualify, and states you 'won't incur any charges'
  • A 100% money-back guarantee if you are not approved for treatment, including the assessment
  • Unusually broad catalogue beyond GLP-1s: microdose semaglutide and tirzepatide, metformin from $19/mo, MIC + B12 from $69/mo, naltrexone/bupropion, sermorelin and NAD+
  • Free shipping on every subscription order and 24/7 clinician access included in the plan price
  • The compounded disclosure is explicit and specific, naming FDA-registered facilities while stating the drugs are not FDA-approved
  • Subscriptions can be cancelled or paused from your account rather than only by email

Cons

  • A $50 non-refundable cancellation fee applies if you cancel after your intake is approved but before the pharmacy processes the order - a charge most competitors do not levy
  • Once the prescription reaches the pharmacy, all sales are final: 'we do not offer refunds for partially used subscription periods'
  • The site runs constant price-increase pressure - a sitewide 'Prices increase soon, lock in today's rate before it goes up' banner, a 'Price increases in' countdown, 'LIMITED TIME' on every plan tier and 'Lock This Price Now' on every product
  • The homepage contradicts itself on tirzepatide, listing it at 'Starting as low as $149/mo' in one block and 'As low as $139/month' in another
  • The $99 headline requires committing to 12 months and paying $1,188 upfront; month to month is $129
  • This offer is not available in Alabama, Arkansas, California, Kentucky, Louisiana, Mississippi, North Carolina, North Dakota or South Carolina
  • No BBB profile and a relatively small Trustpilot sample mean limited independent history to check
  • No published customer phone number, and the compounded disclosure sits on product pages rather than the landing page
Choose bmiMD

MEDVi Quad

View full MEDVi Quad review →
Rating
6.5/10
Monthly Price
$114Cheaper
Medications
sildenafiltadalafilbremelanotide (PT-141)L-citrulline

Pros

  • $114/month, reduced from a stated $179, and the price is all-in: doctor consultation, free rush shipping and 24/7 medical support are included with no separate consultation fee (checked July 28, 2026)
  • Cancel anytime, and the page states you are not charged if you do not qualify
  • All four active ingredients are named openly - PT-141 (bremelanotide), L-citrulline, sildenafil and tadalafil - rather than hidden behind a proprietary blend name
  • Sublingual delivery is a real advantage over tablets: it bypasses first-pass metabolism, so onset is faster and a heavy meal does not blunt absorption the way it can with oral sildenafil
  • Backed by a substantial independent review record - roughly 14,000 Trustpilot reviews at 4.4, with 99% of negative reviews answered
  • A published phone number, email address and physical address, which many competitors in this category omit entirely

Cons

  • 'Peak rigidity guaranteed' appears directly in the product copy. No prescription medication can guarantee an outcome, and this is the most explicit outcome promise we have seen across every provider reviewed on this site
  • The formula stacks two PDE5 inhibitors - sildenafil and tadalafil - and then adds L-citrulline, a nitric oxide precursor. All three act on the same nitric oxide and cGMP pathway, so the blood-pressure-lowering effect compounds three ways rather than one
  • PT-141 adds a fourth agent that independently causes low blood pressure, nausea and flushing. Four actives, four routes to hypotension, and no discussion anywhere on the page of the combined risk
  • Bremelanotide's only FDA approval is as Vyleesi, an autoinjector for premenopausal women with hypoactive sexual desire disorder. Prescribing it to men in a compounded sublingual liquid is off-label and a different route of administration
  • The word FDA does not appear on the page at all. The product is compounded, and the page never states the consequence - that compounded preparations are not reviewed or approved by the FDA for safety, efficacy or quality
  • 'The world's first 4-in-1 formula' and 'hospital-grade power' are unverifiable marketing superlatives attached to a prescription product
  • The advertised Trustpilot score covers MEDVi's business as a whole rather than this specific product
  • The published address is a suite at a Delaware registered-agent building, not a clinical facility
  • Anyone taking nitrates or riociguat must not use this product. The PT-141 component also interacts with 5-HT3 anti-emetics such as ondansetron, and stacking two PDE5 inhibitors makes the nitrate contraindication more dangerous, not less
Choose MEDVi Quad

Feature-by-feature comparison

FeaturebmiMDMEDVi Quad
Monthly Price$129$114
Rating8/106.5/10
Medicationssemaglutide, tirzepatide, metforminsildenafil, tadalafil, bremelanotide (PT-141), L-citrulline
Insurance AcceptedNoNo
Support Hours24/7 clinician access claimed24/7 medical support advertised
Live ChatNoNo
Free ShippingYesYes
Shipping SpeedFree shipping on subscription orders; timeframe not publishedFree rush shipping included in the monthly price
Mobile AppNoNo
Dedicated CoachNot includedNot included
Follow-up Frequency24/7 clinician access with refills delivered on subscription24/7 medical support advertised; follow-up cadence not published
Money-back Guarantee100% refund if you are not approved for treatment; otherwise all sales are final once the prescription reaches the pharmacyNo charge if you do not qualify; no refund policy published for dispensed medication
Cancellation PolicyCancel or pause from your account any time, but a $50 non-refundable fee applies after intake approval and there are no refunds for partially used periodsCancel anytime

Which should you choose?

Choose bmiMD if you:

  • Prefer a higher-rated service (8/10 vs 6.5/10)
  • Value: the full price ladder is published on the product page, not hidden behind a quiz: compounded semaglutide is $129 billed monthly, $119/mo on 3 months ($357), $109/mo on 6 months ($654) and $99/mo on 12 months ($1,188), checked july 26, 2026

Choose MEDVi Quad if you:

  • Want to save $15/month with a more affordable option
  • Want more medication options to choose from
  • Value: $114/month, reduced from a stated $179, and the price is all-in: doctor consultation, free rush shipping and 24/7 medical support are included with no separate consultation fee (checked july 28, 2026)

Website previews

bmiMD

bmiMD website

MEDVi Quad

MEDVi Quad website

Our recommendation

bmiMD comes out ahead with a higher rating of 8/10. It also provides multiple medication options including both semaglutide and tirzepatide.
Get started with bmiMD

Compare other providers

Compare GLP-1 Brands